Literature DB >> 34295579

Splenic and Portal Vein Thrombosis With Concurrent Splenic Infarction: A Rare Manifestation of Essential Thrombocythemia.

Manisha Gulia1, Neha Sharma1, Yajur Arya1, Arshi Syal1, Monica Gupta1.   

Abstract

Mesenteric venous thrombosis (MVT) presents with a wide range of clinical presentations depending on the vessel involved, degree of thrombosis, and the extent of bowel wall ischemia. MVT usually has an insidious presentation and is often a forerunner of an underlying disorder. Essential thrombocythemia (ET) presenting itself as MVT along with splenic infarction is a rare presentation. Here, we report the case of a 54-year-old female with massive splenomegaly, thrombocytosis, and acute splenic and portal venous thrombosis along with multiple splenic infarcts. Bone marrow suggested ET with JAK2V617F mutation positivity. She was managed conservatively and made an uneventful recovery.
Copyright © 2021, Gulia et al.

Entities:  

Keywords:  essential thrombocythemia; mesenteric venous thrombosis; myeloproliferative disorder; portal vein thrombosis; splenic infarction

Year:  2021        PMID: 34295579      PMCID: PMC8291459          DOI: 10.7759/cureus.15768

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  10 in total

1.  Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.

Authors:  M H Denninger; Y Chaït; N Casadevall; S Hillaire; M C Guillin; A Bezeaud; S Erlinger; J Briere; D Valla
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

Review 2.  The diagnostic interface between histology and molecular tests in myeloproliferative disorders.

Authors:  Ayalew Tefferi; James W Vardiman
Journal:  Curr Opin Hematol       Date:  2007-03       Impact factor: 3.284

3.  Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders.

Authors:  D Valla; N Casadevall; M G Huisse; M Tulliez; J D Grange; O Muller; T Binda; B Varet; B Rueff; J P Benhamou
Journal:  Gastroenterology       Date:  1988-04       Impact factor: 22.682

4.  Abdominal vein thrombosis in essential thrombocythemia: prevalence, clinical correlates, and prognostic implications.

Authors:  Naseema Gangat; Alexandra P Wolanskyj; Ayalew Tefferi
Journal:  Eur J Haematol       Date:  2006-07-19       Impact factor: 2.997

5.  Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area.

Authors:  M K Jensen; P de Nully Brown; O J Nielsen; H C Hasselbalch
Journal:  Eur J Haematol       Date:  2000-08       Impact factor: 2.997

Review 6.  The World Health Organization (WHO) classification of the myeloid neoplasms.

Authors:  James W Vardiman; Nancy Lee Harris; Richard D Brunning
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

Review 7.  Venous thrombosis: a multicausal disease.

Authors:  F R Rosendaal
Journal:  Lancet       Date:  1999-04-03       Impact factor: 79.321

Review 8.  Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes.

Authors:  Ozgur Harmanci; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

9.  Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia.

Authors:  Francesco Passamonti; Elisa Rumi; Ester Pungolino; Lucia Malabarba; Paola Bertazzoni; Marina Valentini; Ester Orlandi; Luca Arcaini; Ercole Brusamolino; Cristiana Pascutto; Mario Cazzola; Enrica Morra; Mario Lazzarino
Journal:  Am J Med       Date:  2004-11-15       Impact factor: 4.965

10.  Characterization and Prognosis Significance of JAK2 (V617F), MPL, and CALR Mutations in Philadelphia-Negative Myeloproliferative Neoplasms

Authors:  Roongrudee Singdong; Teerapong Siriboonpiputtana; Takol Chareonsirisuthigul; Adcharee Kongruang; Nittaya Limsuwanachot; Tanasan Sirirat; Suporn Chuncharunee; Budsaba Rerkamnuaychoke
Journal:  Asian Pac J Cancer Prev       Date:  2016-10-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.